- Report
- August 2025
- 198 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 184 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 186 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- August 2025
- 198 Pages
Global
From €3125EUR$3,545USD£2,745GBP
€3473EUR$3,939USD£3,050GBP
- Report
- December 2025
- 194 Pages
Global
From €5157EUR$5,850USD£4,530GBP
- Report
- October 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- March 2025
- 200 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- July 2025
Global
From €4320EUR$4,900USD£3,794GBP
- Report
- April 2025
Global
From €4320EUR$4,900USD£3,794GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1058EUR$1,200USD£929GBP
€1322EUR$1,500USD£1,162GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €882EUR$1,000USD£774GBP
€1102EUR$1,250USD£968GBP
- Report
- December 2025
- 291 Pages
Global
From €5157EUR$5,850USD£4,530GBP
- Report
- May 2025
- 110 Pages
Global
From €4188EUR$4,750USD£3,678GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP
- Report
- September 2025
- 250 Pages
Global
From €3958EUR$4,490USD£3,477GBP

The Antacid market is a segment of the Over the Counter (OTC) Drugs industry. Antacids are used to treat symptoms of acid reflux, heartburn, and indigestion. They are available in a variety of forms, including tablets, liquids, and chewable gummies. Antacids are generally safe and effective, and can be purchased without a prescription.
The Antacid market is highly competitive, with a wide range of products available from both large and small companies. Many of the products are marketed as being fast-acting and long-lasting, and some are formulated to provide additional benefits such as relief from gas and bloating.
Some of the companies in the Antacid market include GlaxoSmithKline, Pfizer, Bayer, Johnson & Johnson, Novartis, and Procter & Gamble. Show Less Read more